Donate

Latest news & articles

Latest news
Changes to Novo Nordisk® insulin portfolio over the next two years
News

Changes to Novo Nordisk® insulin portfolio over the next two years

Novo Nordisk has announced that over the next two years, some of their older generations of insulin products, including those with multiple presentations, will be phased out. This is part of a global insulin portfolio consolidation and is not a result of any safety, efficacy, or quality-related concerns.   This process will take place over […]
Supporting the next generation of type 1 diabetes scientists
Research

Supporting the next generation of type 1 diabetes scientists

JDRF Australia is committed to a vision of a world without type 1 diabetes (T1D) through funding the best science. But research can only be done by researchers. This is why we have a strong focus on not only funding established researchers but also investing in the development of those earlier on in their career […]
JDRF Australia welcomes new CEO, Sydney Yovic
News

JDRF Australia welcomes new CEO, Sydney Yovic

JDRF Australia has welcomed Sydney Yovic to the organisation as the new Chief Executive Officer.   Sydney joins with extensive experience in the type 1 diabetes (T1D) space following 12 years with Breakthrough T1D (formerly JDRF International), where she spent 8 years in the research department, and mostly recently was the Head of Strategy and Chief […]
Farewell from Mike Wilson OAM
News

Farewell from Mike Wilson OAM

A Note of thanks as I retire as CEO of JDRF Australia “After two decades as CEO of JDRF Australia, the time has come for me to step down and pass the baton to the next leader who will continue this organisation’s incredible journey. It’s with a happy heart and a deep sense of gratitude […]
Preschool-aged children in early-stage type 1 diabetes have changes in blood sugar levels, even before they are officially diagnosed
Research

Preschool-aged children in early-stage type 1 diabetes have changes in blood sugar levels, even before they are officially diagnosed

New research has found that preschoolers who are in the early, pre-symptomatic stages of type 1 diabetes (T1D) have changes in blood sugar levels well before symptoms appear. We used to think that people developed T1D when they first showed the ‘4T’ symptoms: thirst, tiredness, toilet (increased urination) and thin (weight loss). This is when […]
New clinical trial looking for participants to test semaglutide in type 1 diabetes
Research

New clinical trial looking for participants to test semaglutide in type 1 diabetes

A new clinical trial investigating the use of semaglutide for type 1 diabetes (T1D) has launched in Sydney and is actively recruiting. The trial, called REducing Cardiometabolic Risk with SEmaglutide in Type 1 diabetes (The RESET1 study) is looking for adults to test whether semaglutide, a medication currently used to treat type 2 diabetes, can […]
Australian researchers set to develop new insulin formulation which could transform type 1 diabetes management
Research

Australian researchers set to develop new insulin formulation which could transform type 1 diabetes management

Australian researcher Professor Christoph Hagemeyer from Monash University and colleagues have received over $750,000 to take their innovative new insulin formulation to the next stage of research.  In people with type 1 diabetes (T1D), the immune system incorrectly attacks the cells of the pancreas that normally produce insulin, a hormone essential to regulate blood sugar […]
Parliamentary Inquiry recommendations announced: JDRF Australia applauds steps towards improved diabetes care and research
Advocacy

Parliamentary Inquiry recommendations announced: JDRF Australia applauds steps towards improved diabetes care and research

JDRF Australia is pleased to acknowledge the recent report from the Parliamentary Committee of Inquiry into Diabetes, which makes 23 recommendations for improving health outcomes for Australians with all forms of diabetes – including type 1 diabetes (T1D). We were delighted to be on hand when Dr Mike Freelander and his Committee handed down their […]
One Walk is moving to March 2025!
Fundraising

One Walk is moving to March 2025!

Dear JDRF Community,  We are thrilled to share some exciting news about our flagship fundraiser, One Walk. To maximise our impact and align with exciting new initiatives, we are moving the event from October 2024 to March 2025! This change brings numerous benefits to our community and organisation.  By shifting One Walk to March 2025, […]
New guidance set to change the way we diagnose type 1 diabetes
Research

New guidance set to change the way we diagnose type 1 diabetes

Screening and monitoring will bring forward diagnoses and make early detection of the condition a reality Type 1 diabetes (T1D) diagnoses could soon be transformed with newly released guidance outlining how to detect and monitor early-stage T1D, before the point of symptom onset. The chronic autoimmune condition is traditionally diagnosed when elevated blood glucose levels […]
Three Early to Mid-Career researchers (EMCRs) awarded the Tim Welborn Fellowship
Research

Three Early to Mid-Career researchers (EMCRs) awarded the Tim Welborn Fellowship

Three Early to Mid-Career researchers (EMCRs) awarded the Tim Welborn EMCR Fellowship JDRF Australia is happy to announce that three promising researchers will be supported under the Tim Welborn Early-to-Mid Career Research (EMCR) Fellowship for basic research. This award funds the next generation of type 1 diabetes (T1D) researchers to ensure their career development is […]
New partnership: JDRF & SynxBody Q&A
News

New partnership: JDRF & SynxBody Q&A

We recently caught up with Rachael Ferguson, Synxbody CEO and mum to a child with type 1 diabetes (T1D).   Synxbody is a podiatry and footcare company, founded by Rachael and her business partner in 2011. They recently entered into partnership with JDRF Australia, with a contribution of $1.00 from every online order to JDRF.   You […]
JDRF Australia CEO, Mike Wilson OAM, to retire from role
News

JDRF Australia CEO, Mike Wilson OAM, to retire from role

The JDRF Australia Board is today announcing that after 20 years of dedicated leadership, Chief Executive Officer (CEO) Mike Wilson has decided the time is right to retire from his role later this year. The Board is thankful for the significant contribution Mike has made over many years, including making substantial progress for people with […]
The next chapter of JDRF’s story: Breakthrough T1D
News

The next chapter of JDRF’s story: Breakthrough T1D

Welcome to the next chapter of our story.  Over the past few years, we’ve had feedback from the type 1 diabetes (T1D) community and potential supporters about how our organisation, and particularly our name, is perceived. We’ve listened, and we’re very excited to share that JDRF is commencing a global rebrand.   As a result, we’ll […]
$3M invested for researchers working towards precision medicine for type 1 diabetes
News

$3M invested for researchers working towards precision medicine for type 1 diabetes

JDRF Australia and JDRF International have announced over $3m AUD in funding for researchers aiming to improve health outcomes for the type 1 diabetes (T1D) community by making precision medicine possible.   Precision medicine has delivered great benefits in other disease areas, such as cancer, and involves treatment that is tailored to a person’s genes, environment, […]
Our Volunteer of the Year winners 2024
News

Our Volunteer of the Year winners 2024

It’s National Volunteer Week and this year’s theme is ‘Something for Everyone’.   JDRF Australia was founded by volunteers in 1972, volunteers are at the core of all that we do, and we want to recognise and acknowledge all our volunteers who dedicate their time and effort to help us create a world without type […]
Exciting partnership: JDRF & SynxBody
News

Exciting partnership: JDRF & SynxBody

JDRF Australia has announced a new partnership with SynxBody Australia, an Australian footcare company, in a collaborative move towards enhancing awareness, education and support for Australians living with type 1 Diabetes (T1D).  SynxBody specialises in premium, affordable footcare products designed to effectively treat common ailments and enhance comfort for people from all walks of life. […]
Advocacy Spotlight: Meet Joanne & Dougal
News

Advocacy Spotlight: Meet Joanne & Dougal

Dougal has been living with type 1 diabetes (T1D) since the age of 4, a journey that began when he complained of sore legs. Despite the absence of any family history of T1D, Joanne (Jo), a health professional and parent, quickly recognised the signs, drawing on her expertise and a colleague’s experience as a T1D […]